PEPLIN

WIPO WIPO 2010

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke PEPLIN wurde als Wortmarke am 08.10.2010 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 11. November 2021

Markenform Wortmarke
Aktenzeichen 1058228
Länder Albanien Armenien Aserbaidschan Bosnien und Herzegowina Bahrain Bonaire, Sint Eustatius und Saba Bhutan Botswana Weißrussland Schweiz China Ägypten Georgien Kroatien Israel Iran Island Japan Kenia Kirgisistan Südkorea Liechtenstein Marokko Monaco Moldawien Montenegro Madagaskar Mazedonien Mosambik Namibia Norwegen Oman Serbien Russland Sudan Singapur San Marino Sint Maarten Syrien Turkmenistan Türkei Ukraine Usbekistan Vietnam Sambia
Basismarke DK Nr. VA 2010 02619, 02. September 2010
Anmeldedatum 08. Oktober 2010
Ablaufdatum 08. Oktober 2020

Markeninhaber

Industriparken 55
2750 Ballerup
DK

Waren und Dienstleistungen

05 Vaccines, pharmaceuticals, medical preparations, diagnostic preparations and therapeutic agents for the treatment, prevention and diagnosis of diabetes, dermatological, respiratory and/or inflammatory conditions namely, acne, angina, arthritis, aspiration pneumonia, emphysema, gastroenteritis, intestinal flu, necrotizing enterocolitis, pelvic inflammatory disease, pharyngitis, PID, pleurisy, raw throat, redness, rubor, sore throat, stomach flu and urinary tract infections, chronic inflammatory demyelinating polyneuropathy, chronic inflammatory demyelinating polyradiculoneuropathy; vaccines, pharmaceuticals, medical preparations, diagnostic preparations and therapeutic agents for the treatment of cancers, namely, tumors, sarcomas, carcinomas and melanomas including tumors of the colon, breast, neck, throat, bladder, brain, liver, pancreas, adrenal glands, lymph, testicles, uterus, ovaries, lungs as well as solid and blood borne tumors such as ABL l proto-oncogene, AIDS related cancers, acoustic neuroma, acute lymphocyte leukemia, acute myeloid leukemia, adenocystic carcinoma, adrenocortical cancer, agnogenic myeloid metaplasia, alopecia, alveolar soft-part sarcoma, anal cancer, angio-sarcoma, aplastic anemia, astrocytoma, ataxia-telangiectasia, basal cell carcinoma, bladder cancer, bone cancers, bowel cancer, brain stem glioma, brain and CNS tumors, breast cancer, CNS tumors, carcinoid tumors, cervical cancer, childhood brain tumors, childhood cancer, childhood leukemia, childhood soft tissue sarcoma, chondrosarcoma, choriocarcinoma, chronic lymphocytic leukemia, chronic myeloid leukemia, colorectal cancers, cutaneous T-cell lymphoma, dermatofibrosarcoma proruberans, desmoplastic-small-round-cell-tumor, ductal carcinoma, endocrine cancers, endometrial cancer, ependymoma, esophageal cancer, Ewing's sarcoma, extra-hepatic bile duct cancer, eye cancer, fallopian tube cancer, fanconi anemia, fibrosarcoma, gall bladder cancer, gastric cancer, gastrointestinal cancers, gastrointestinal carcinoid tumor, genitourinary cancers, germ cell tumors, gestational trophoblastic disease, glioma, gynecological cancers, hematological malignancies, hairy cell leukemia, head and neck cancer, hepatocellular cancer, hereditary breast cancer, histiocytosis, Hodgkin's disease, human papillomavirus, hydatidiform raole, hypercalcemia, hypopharynx cancer, intraocular melanoma, islet cell cancer, Kaposi's sarcoma, kidney cancer, Langerhan's cell histiocytosis, laryngeal cancer, leiomyosarcoma, leukemia, Li-Fraumeni syndrome, lip cancer, liposarcoma, liver cancer, lung cancer, lymphedema, lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, male breast cancer, malignant rhabdoid tumor of kidney, medulloblastoma, melanoma, Merkel cell cancer, mesothelioma, metastatic cancer, mouth cancer, multiple endocrine neoplasia, mycosis fungoides, myelodysplastic syndromes, myeloma, myeloproliferative disorders, nasal cancer, nasopharyngeal cancer, nephroblastoma, neuroblastoma, neurofibromatosis, Nijmegen breakage syndrome, non-melanoma skin cancer, non-small cell lung cancer, ocular cancers, oesophageal cancer, oral cavity cancer, oropharynx cancer, osteosarcoma, ostomy, ovarian cancer, pancreas cancer, paranasal cancer, parathyroid cancer, parotid gland cancer, penile cancer, peripheral neuroectodermal tumors, pituitary cancer, polycythemia vera, prostate cancer, rare cancers and associated disorders, renal cell carcinoma, retinoblastoma, rhabdomyosarcoma, Rothmund-Thomson syndrome, salivary gland cancer, schwannoma, Sezary syndrome, skin cancer, small cell lung cancer, small intestine cancer, soft tissue sarcoma, spinal cord tumors, squamous cell carcinoma, stomach cancer, synovial sarcoma, testicular cancer, thymus cancer, thyroid cancer, transitional cell cancer of the bladder, transitional cell cancer of the renal, pelvis and ureter, trophoblastic cancer, urethral cancer, urinary system cancer, uroplakins, uterine sarcoma, uterus cancer, vaginal cancer, vulva cancer, Waldenstrom's macroglobulinemia and Wilms' tumor; pharmaceutical preparations namely, alimentary tract and metabolism, antineoplastic and immunomodulating agents, anti-infectives for systemic use; dermatological preparations
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
10. November 2021 2021/45 Gaz Löschung
02. April 2013 2013/22 Gaz SY Ablehnung
19. Oktober 2012 2012/43 Gaz TR Ablehnung
22. Mai 2012 2012/21 Gaz TM Ablehnung
11. Januar 2012 2012/4 Gaz RU RAW: Rule 18ter(2)(i) GP following a provisional refusal
09. Januar 2012 2012/5 Gaz BY Ablehnung
16. Dezember 2011 2011/51 Gaz VN Ablehnung
14. Dezember 2011 2011/51 Gaz SY Ablehnung
09. Dezember 2011 2012/2 Gaz ME Ablehnung
07. Dezember 2011 2011/50 Gaz MG Ablehnung
02. Dezember 2011 2011/51 Gaz CH Ablehnung
22. November 2011 2011/47 Gaz GE Ablehnung
21. November 2011 2011/49 Gaz HR Ablehnung
17. November 2011 2011/49 Gaz BA Ablehnung
04. November 2011 2011/45 Gaz UA Ablehnung
03. November 2011 2012/5 Gaz IL Ablehnung
27. Oktober 2011 2011/45 Gaz RS Ablehnung
14. Oktober 2011 2011/42 Gaz AM Ablehnung
09. Oktober 2011 2011/41 Gaz KR Ablehnung
21. September 2011 2011/40 Gaz KG Ablehnung
20. September 2011 2011/39 Gaz RU Ablehnung
16. September 2011 2011/37 Gaz MD Ablehnung
15. August 2011 2011/40 Gaz CN Ablehnung
15. Juli 2011 2011/29 Gaz NO Ablehnung
07. Juli 2011 2011/28 Gaz SM Ablehnung
06. Juni 2011 2011/23 Gaz IS Ablehnung
16. Mai 2011 2011/27 Gaz SX Ablehnung
04. Mai 2011 2011/25 Gaz SG Ablehnung
14. April 2011 2011/15 Gaz JP Ablehnung
02. Dezember 2010 2010/51 Gaz Korrektur
08. Oktober 2010 2010/48 Gaz DK Eintragung

ID: 141058228